# Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects

> **NCT00864500** · PHASE1 · COMPLETED · sponsor: **Actavis Inc.** · enrollment: 224 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Clobetasol Propionate 0.05% lotion, single exposure
- **DRUG:** Clobex TM 0.05% Lotion, single exposure

## Key facts

- **NCT ID:** NCT00864500
- **Lead sponsor:** Actavis Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 224 (ACTUAL)
- **Last updated:** 2019-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864500, "Pivotal Bioequivalence Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00864500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*